StockCIK 1787306

Arcutis Biotherapeutics, Inc. (ARQT): Insider Trades and Fund Holdings

In the past 12 months, Arcutis Biotherapeutics, Inc. insiders reported 0 open-market purchases worth $0 and 10 sales worth $2.13M; 5 of the sales were reported as made under a 10b5-1 trading plan.

0Insider buys, 12 months

$0Bought by insiders, 12 months

$2.13MSold by insiders, 12 months

1Tracked funds holding

Recent insider trades

Open-market purchases (code P) and sales (code S) from Form 4. Grants, option exercises and gifts are not shown. Latest filing: Oct 19, 2026.

Recent ARQT insider trades
Filed	Traded	Insider	Role	Type	Shares	Price ($)	Value	Holding	Filing
Oct 19	Oct 15	Howard G. WelgusDirector	Director	▼ SELL10b5-1	4,728	26.93	$127K	−12%	Form 4 ↗
Sep 18	Sep 16	Masaru MatsudaSee Remarks	See Remarks	▼ SELL10b5-1	3,674	25.00	$92K	−3.2%	Form 4 ↗
Sep 17	Sep 15	Howard G. WelgusDirector	Director	▼ SELL10b5-1	4,730	24.18	$114K	−12%	Form 4 ↗
Sep 10	Sep 8	Masaru MatsudaSee Remarks	See Remarks	▼ SELL10b5-1	9,989	25.03	$250K	−7.9%	Form 4 ↗
Aug 28	Aug 27	Terrie CurranDirector	Director	▼ SELL	38,200	25.03	$956K	−62%	Form 4 ↗
Aug 24	Aug 20	Terrie CurranDirector	Director	▼ SELL	1,072	26.04	$28K	−4.4%	Form 4 ↗
Aug 21	Aug 19	Patrick BurnettSee Remarks	See Remarks	▼ SELL	1,697	27.00	$46K	−1.4%	Form 4 ↗
Aug 19	Aug 17	Howard G. WelgusDirector	Director	▼ SELL10b5-1	4,730	26.18	$124K	−12%	Form 4 ↗
Aug 13	Aug 11	Patrick BurnettSee Remarks	See Remarks	▼ SELL	8,300	26.52	$220K	−6.5%	Form 4 ↗
Aug 13	Aug 12	Patrick BurnettSee Remarks	See Remarks	▼ SELL	6,700	26.08	$175K	−5.3%	Form 4 ↗

Source: SEC Form 4 filings, retrieved Oct 28, 2026. How we read filings

Insiders who traded in the past year

Insider	Role	Bought	Sells	Sold	Latest
Howard G. Welgus	Director	$0	3	$366K	Oct 19, 2026
Masaru Matsuda	See Remarks	$0	2	$342K	Sep 18, 2026
Terrie Curran	Director	$0	2	$984K	Aug 28, 2026
Patrick Burnett	See Remarks	$0	3	$441K	Aug 21, 2026

Tracked funds that report ARQT

From each fund's latest 13F. Holdings are as of quarter end and are filed up to 45 days later.

Fund	Quarter	Shares	Value	% of portfolio	Change
Renaissance Technologies	Q2 2026	58,399	$1.53M	0.00%	▼ −86.8%

Source: SEC Form 13F-HR filings, retrieved Oct 28, 2026. How we read filings

Reading these numbers

Insiders sell for many reasons: taxes, diversification, a house. Purchases with their own money are rarer and are usually read as more informative. A Form 4 is due within two business days of the trade. How to read a Form 4 →